Literature DB >> 11841427

Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma.

Inger Marie S Dahl1, Thomas Rasmussen, Goran Kauric, Anne Husebekk.   

Abstract

We report on the different expression of CD56 and CD44 in plasma cells (PCs) simultaneously collected from bone marrow, extramedullary locations and peripheral blood in seven patients with multiple myeloma. Extramedullary PCs showed absence of CD56. In the bone marrow, however, subsets with varying CD56 expression were found in five out of seven patients, with one subset corresponding to that of extramedullar PCs. This differs from the de novo downregulation of CD56 in PC leukaemia, and suggests different mechanisms of spread of myeloma cells. CD44 expression was generally upregulated on extramedullary PCs. In three of the patients we investigated the clonal origin of extramedullary myeloma cells by sequencing the variable portion of the heavy chain immunoglobulin gene in phenotypically defined PCs isolated from different locations. In each patient we found malignant PCs with different homing behaviour originating from a common precursor cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841427     DOI: 10.1046/j.1365-2141.2002.03258.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

1.  Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.

Authors:  Mathew Weinstock; Yosra Aljawai; Elizabeth A Morgan; Jacob Laubach; Muriel Gannon; Aldo M Roccaro; Cindy Varga; Constantine S Mitsiades; Claudia Paba-Prada; Robert Schlossman; Nikhil Munshi; Kenneth C Anderson; Paul P Richardson; Edie Weller; Irene M Ghobrial
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

Review 2.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

Review 3.  Immunophenotyping in multiple myeloma and related plasma cell disorders.

Authors:  Shaji Kumar; Teresa Kimlinger; William Morice
Journal:  Best Pract Res Clin Haematol       Date:  2010-09       Impact factor: 3.020

4.  CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Authors:  Takakazu Kawase; Minoru Hamazaki; Michinori Ogura; Yoshiaki Kawase; Toshihiko Murayama; Yoshio Mori; Hirokazu Nagai; Masatoshi Tateno; Takashi Oyama; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Tomoki Naoe; Toshitada Takahashi; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

5.  Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

Authors:  Valentina Marchica; Fabrizio Accardi; Paola Storti; Cristina Mancini; Eugenia Martella; Benedetta Dalla Palma; Marina Bolzoni; Katia Todoerti; Magda Marcatti; Chiara Schifano; Sabrina Bonomini; Gabriella Sammarelli; Antonino Neri; Maurilio Ponzoni; Franco Aversa; Nicola Giuliani
Journal:  Int J Hematol       Date:  2016-10-03       Impact factor: 2.490

6.  Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.

Authors:  Ludger Klewes; Rhea Vallente; Eric Dupas; Carolin Brand; Dietrich Grün; Amanda Guffei; Chirawadee Sathitruangsak; Julius A Awe; Alexandra Kuzyk; Daniel Lichtensztejn; Pille Tammur; Tiiu Ilus; Anu Tamm; Mari Punab; Morel Rubinger; Adebayo Olujohungbe; Sabine Mai
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

7.  Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.

Authors:  Maria G Ioannou; Efstathios Stathakis; Andreas C Lazaris; Thomas Papathomas; Evangelos Tsiambas; George K Koukoulis
Journal:  Pathol Oncol Res       Date:  2008-06-14       Impact factor: 3.201

8.  Relapsing Extramedullary Multiple Myeloma Presenting As Acute Liver Failure.

Authors:  Hafiza Wajeeha Javaid; Farrukh Munir; Saman Bahram
Journal:  Cureus       Date:  2021-12-28

9.  An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.

Authors:  Shoko Nakayama; Taiji Yokote; Yuji Hirata; Kazuki Iwaki; Toshikazu Akioka; Takuji Miyoshi; Ayami Takayama; Uta Nishiwaki; Yuki Masuda; Toshiyuki Ikemoto; Hidema Tanaka; Yasuichiro Nishimura; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Diagn Pathol       Date:  2012-09-28       Impact factor: 2.644

10.  Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.

Authors:  Eva Kriegova; Regina Fillerova; Jiri Minarik; Jakub Savara; Jirina Manakova; Anna Petrackova; Martin Dihel; Jana Balcarkova; Petra Krhovska; Tomas Pika; Petr Gajdos; Marek Behalek; Michal Vasinek; Tomas Papajik
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.